Overview

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

Status:
RECRUITING

Trial end date:
2025-11-30

Target enrollment:

Participant gender:

Summary

This study aims to compare the efficacy and safety of the combination drug Clotrimazole+Lactulose with the monocomponent product Canesten (clotrimazole) in adult women diagnosed with candidal vulvovaginitis. The primary objective was to confirm the superiority of the combination drug in terms of clinical and microbiological response on Day 25 of the study.

Phase:

PHASE2

Details

Lead Sponsor:

AVVA Pharmaceuticals Ltd.

Treatments:

Clotrimazole
Lactulose